Suppr超能文献

二级淋巴组织趋化因子是CC趋化因子受体CCR7的功能性配体。

Secondary lymphoid-tissue chemokine is a functional ligand for the CC chemokine receptor CCR7.

作者信息

Yoshida R, Nagira M, Kitaura M, Imagawa N, Imai T, Yoshie O

机构信息

Shionogi Institute for Medical Science, 2-5-1 Mishima, Settsu-shi, Osaka 566, Japan.

出版信息

J Biol Chem. 1998 Mar 20;273(12):7118-22. doi: 10.1074/jbc.273.12.7118.

Abstract

Secondary Lymphoid-tissue Chemokine (SLC) is a recently identified CC chemokine that is constitutively expressed in various lymphoid tissues and is a potent and specific chemoattractant for lymphocytes. The SLC gene and the gene encoding another lymphocyte-specific CC chemokine, EBI1-ligand chemokine (ELC), form a mini-cluster at human chromosome 9p13. Here, we show that SLC is a high affinity functional ligand for chemokine receptor 7 (CCR7) that is expressed on T and B lymphocytes and a known receptor for ELC. SLC induced a vigorous calcium mobilization in murine L1.2 cells stably expressing human CCR7. SLC tagged with the secreted form of alkaline phosphatase (SLC-SEAP) showed specific binding to CCR7 that was fully competed by SLC with an IC50 of 0.5 nM. SLC also induced a vigorous chemotactic response in CCR7-expressing L1.2 cells with a typical bell-shaped dose-response curve and a maximal migration at 10 nM. When assessed using CCR7-transfected L1.2 cells, SLC and ELC were essentially equivalent in terms of cross desensitization in calcium mobilization via CCR7, cross-competition in binding to CCR7, and induction of chemotaxis via CCR7. SLC and ELC were also shown to fully share receptors expressed on cultured normal T cells known to express CCR7. Notably, however, SLC was somehow less efficient in cross-desensitization against ELC in calcium mobilization and in cross-competition with ELC for binding when assessed using cultured normal T cells. Thus, SLC and ELC, even though sharing only 32% amino acid identity, constitute a genetically and functionally highly related subgroup of CC chemokines.

摘要

二级淋巴组织趋化因子(SLC)是最近发现的一种CC趋化因子,在各种淋巴组织中组成性表达,是淋巴细胞的一种强效特异性化学引诱剂。SLC基因与编码另一种淋巴细胞特异性CC趋化因子EBI1配体趋化因子(ELC)的基因在人类染色体9p13处形成一个小簇。在此,我们表明SLC是趋化因子受体7(CCR7)的高亲和力功能性配体,CCR7在T和B淋巴细胞上表达,且是ELC的已知受体。SLC在稳定表达人CCR7的鼠L1.2细胞中诱导强烈的钙动员。用分泌型碱性磷酸酶标记的SLC(SLC-SEAP)显示与CCR7有特异性结合,SLC能完全竞争这种结合,IC50为0.5 nM。SLC在表达CCR7的L1.2细胞中也诱导强烈的趋化反应,具有典型的钟形剂量反应曲线,在10 nM时迁移达到最大值。当使用转染CCR7的L1.2细胞进行评估时,就通过CCR7的钙动员中的交叉脱敏、与CCR7结合中的交叉竞争以及通过CCR7诱导趋化作用而言,SLC和ELC基本相当。SLC和ELC还显示完全共享在已知表达CCR7的培养正常T细胞上表达的受体。然而,值得注意的是,当使用培养的正常T细胞进行评估时,SLC在钙动员中对ELC的交叉脱敏以及与ELC竞争结合方面效率略低。因此,SLC和ELC尽管氨基酸同一性仅为32%,但构成了CC趋化因子中在遗传和功能上高度相关的一个亚组。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验